Jones completed a M.D. and Ph.D. from Stanford University. She is a board-certified radiation oncologist specialized training in radiosurgery, with graduate and postdoctoral training in both cancer biology and general immunology.[1] Her doctoral advisor was Dale Umetsu [Wikidata]. Jones' dissertation in 2001 was titled, Identification of Tapr, a T cell and airway phenotype regulatory locus, and positional cloning of the Tim gene family.[2]
From 2001 to 2003, Jones positionally cloned the T-cell immunoglobulin mucin (TIM) gene family and demonstrated the genetic association between TIMs and immune response profiles. As a radiation oncologist, her research is focused on developing immune-based therapies that synergize with radiation to produce optimal anti-tumor immune responses. Jones develops improved methods to characterize, sort, and perform functional studies of nanoparticles, and has established a translational EV analysis pipeline, with instrumentation for preparation, analysis, counting, and cytometric study of extracellular vesicles.[3]
References
^"Principal Investigators". NIH Intramural Research Program. Retrieved 2020-09-21. This article incorporates text from this source, which is in the public domain.
^McIntire, Jennifer Jones (2001). Identification of Tapr, a T cell and Airway Phenotype Regulatory locus, and positional cloning of the TIM gene family (Ph.D. thesis). Stanford University. OCLC245537990.
